Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. - Wikidata - wikimedia - TriplyDB

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

http://www.wikidata.org/entity/Q38067435

about

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system Surveillance and Care of the Gynecologic Cancer Survivor Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Advanced ovarian cancer: what should be the standard of care?Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment?Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Serous tubal intraepithelial carcinoma: an incidental finding at the time of prophylactic bilateral salpingo-oophorectomy.Novel population of small tumour-initiating stem cells in the ovaries of women with borderline ovarian cancer KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma Tubal origin of ovarian low-grade serous carcinoma.Incessant ovulation and ovarian cancer - a hypothesis re-visited IMP3 signatures of fallopian tube: a risk for pelvic serous cancers.Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms.The transcriptomic profile of ovarian cancer grading Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.Primary fallopian tube carcinoma: review of MR imaging findings Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.Examination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma.Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.Tubal ligation and ovarian cancer risk in a large cohort: Substantial variation by histological type Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas.Protective effects of vitamin D3 on fimbrial cells exposed to catalytic iron damage Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Ovarian Carcinosarcoma and Its Association with Mature Cystic Teratoma and Primary Tubal Carcinoma.Understanding Lymphatic Drainage Pathways of the Ovaries to Predict Sites for Sentinel Nodes in Ovarian Cancer.Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.Incidental (Prophylactic) Salpingectomy at Benign Gynecologic Surgery and Cesarean Section: a Survey of Practice in Austria.Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface.Early preinvasive lesions in ovarian cancer.Epidemiology of ovarian cancer: a review.Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.High-grade serous carcinoma of tubo-ovarian origin: recent developments.In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose.Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.Ovarian and tubal cancer in Denmark: an update on incidence and survival.Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.

P2860

Q26747279-C1B5AD93-AA15-45E8-BF58-C19928B865B5 Q26748510-1B9BADCC-57EF-413C-B5B9-5A332D1B8DAF Q26799810-B149C0FE-ED94-48B1-AE30-7EE7E75C6F64 Q26852127-5C15C687-7642-4B50-A424-8B8BC82A27DC Q27852053-BDAE67C4-7AFB-4225-BC05-861E18FE1CBF Q28085485-9533529F-F406-449C-8D9B-4A90C46B83A9 Q30252854-1287144B-E7A8-4475-8168-3BFD147C476B Q30300317-E01F3C4A-EE38-4F47-9DCC-11CBD87FCC25 Q30818695-3E2F9FBD-ED69-4126-BB22-1B35A126331B Q33893010-83A3014B-5C49-4EF7-95EE-20CBED03D6D3 Q34383567-675CEC87-2535-40C4-8AE8-21E1DDE08219 Q34416449-B1C57D59-9736-426B-9E13-97C7C2B7F0BC Q34504360-B37C578E-FFD0-4AE4-AED0-F6818B47D9AC Q34528553-A1E06314-D30A-4C21-BD7F-1BEA0BD973C2 Q35032309-98D14665-4589-4B80-AAD6-2A5914D0984B Q35680361-2C8BF3C8-9DC1-4F5C-A10D-1EDBA951C11D Q35886692-F30386D0-04C5-459D-9339-4A0C17B01220 Q35902265-A5FB4F00-6771-4319-A8BF-04118DDA5454 Q36309548-957B0131-174E-414C-8C50-09672CC7A496 Q36409618-9AEEA29A-5159-4C72-8FCC-AE483C1CEE73 Q36416465-C07FA25D-D8E6-439A-9FB4-E8ADA8BA252D Q36799895-57E52216-D794-4E7C-A1BA-383CB50C0394 Q36873800-D9BDB61E-7453-4F27-87C1-BAD78FE33B15 Q37017956-5121DE3E-E25C-48C3-AE12-5DBA2654DA2D Q37119791-CAB89014-A8C9-40F1-8D5D-9CEBEFCAA699 Q37225222-4D301DCD-1803-429F-9757-7AA1FE9671AA Q37363874-05A40238-02F2-42A1-982A-64D31E94A5B9 Q37409644-0C3D7DE7-06B8-4E7C-918D-1710CA8E1FE4 Q37516304-801743B2-53B5-445F-BDFB-58370BF972EA Q37525227-E092F051-B64D-41A4-B0E5-9AB206634FB3 Q37688456-10C34E63-6750-452A-B621-617E52CFD9CD Q37719090-EC7E6CE1-4B80-4E8C-BBFE-FA5FF9FB00DB Q37720438-B0484108-99BC-4657-BF5B-6EAB2856DFA0 Q38150173-B812341A-1DFC-4792-B6BD-5E420284B144 Q38687061-BA21BB11-2418-4B19-8E11-24BE4D77C8B5 Q38820442-D4133C8D-BF64-4BFA-BC8C-E0BA27706162 Q39035704-4B042C15-3312-4F8E-B5A8-6110B6FF4AAE Q39212515-0732BB58-52D1-4DBD-A854-9AA46D2F4FDA Q39563666-A8347942-1030-4A1C-9B66-FC27FAF7BE06 Q40057309-54E2628C-93F1-4AD0-B8F5-77B0446F8A56

P2860

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

http://www.wikidata.org/entity/Q38067435

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

@en

type

label

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

@en

prefLabel

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

@en

P1433

Q38067435-09DF6256-6AD3-46C8-9B95-85B18B16FEC7

P1476

Q38067435-CDE2BB3A-56C4-474F-AA76-8565A866A79A

P2093

Q38067435-29135DE6-2A0C-45D3-9F3C-220A3BBDB27B

Q38067435-3884F9D1-2F1E-4B32-ABF4-5A68FD371574

Q38067435-58BD73CC-E43F-4CF5-99B8-002B1B3E045E

P2860

Q38067435-028F5282-16CD-4BE8-8EB6-DCD2C339BEFA

Q38067435-05454C15-8D9C-40E5-AE1A-CD5B600C96D5

Q38067435-07B8E341-AE74-474D-82DE-28E2CA307196

Q38067435-0A8EDBE9-8886-49EA-BF2E-CBD7B6016DA8

Q38067435-0D489CBA-29B4-47E2-8E23-63F0AA21B2BC

Q38067435-15D73FB2-D7FF-48A6-A71D-0C693D88BF3F

Q38067435-20439DEF-FE3C-4275-83D1-6CF91D9E6733

Q38067435-2805DD0A-0F6B-408C-9D42-081C26CFA28C

Q38067435-2DC4DE31-9D68-4477-BF08-63F7B8D89465

Q38067435-30CC082E-7447-4761-8074-AC80BCF350B1

P304

Q38067435-D1C23707-A7D3-482E-A8B6-D79E6AE31631

P31

Q38067435-B6E59193-32B6-41E2-8422-8F0766AE8380

Q38067435-abf7235e-54a7-43d5-8777-4d9d7a8f5339

P356

Q38067435-3A1C6D3E-9394-4E11-A6BD-BC989F2FF1D3

P433

Q38067435-59DAEB44-D83C-49AF-97C1-48633E92949E

P478

Q38067435-31366C7C-E629-4501-89CB-0D5203A2FC50

P577

Q38067435-5EB611F9-78A2-4327-A2EC-6E098A47B220

P5875

Q38067435-D42245F4-ADEE-4A5D-A3AE-D1D1321946A2

P698

Q38067435-C7282240-6FB3-482C-B617-64CBD174C8C5

P921

Q38067435-828858A6-D227-4104-B55E-A5053F28EB60

P356

P1433

P1476

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

@en

P2093

Ie-Ming Shih

http://www.w3.org/2001/XMLSchema#string

Robert J Kurman

http://www.w3.org/2001/XMLSchema#string

Russell Vang

http://www.w3.org/2001/XMLSchema#string

P2860

The post-reproductive Fallopian tube: better removed?

K-ras mutations in Müllerian inclusion cysts associated with serous borderline tumors of the ovary.

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.

Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma.

The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory

Disabled-2 inactivation is an early step in ovarian tumorigenicity.

Incessant ovulation--a factor in ovarian neoplasia?

Precursor lesions of ovarian epithelial malignancy.

TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma--evidence supporting the clonal relationship of the two lesions.

P304

44-58

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.12046

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233929192

http://www.w3.org/2001/XMLSchema#string

P698

23240669

http://www.w3.org/2001/XMLSchema#string

P921